Xenophagy in Helicobacter pylori - And Epstein-Barr virus-induced gastric cancer

Journal of Pathology

Volumn 233, Issue 2, 2014, Pages 103-112

  Zhang, Lin ^a   Sung, Joseph J Y ^a   Yu, Jun ^a   Ng, Siew C ^a   Wong, Sunny H ^a   Cho, Chi H ^a,b   Ng, Simon S M ^b   Chan, Francis K L ^a   Wu, William K K ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

autophagy; EBV; gastric cancer; H. pylori

Indexed keywords

CYTOPLASM PROTEIN; ONCOPROTEIN; VACUOLATING TOXIN; VIRULENCE FACTOR;

AUTOLYSOSOME; AUTOPHAGOSOME; CELL MOTILITY; CELL ORGANELLE; CELL PROLIFERATION; DOWN REGULATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; IMMUNITY; LYSOSOME; NONHUMAN; PATHOGENICITY ISLAND; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH CARCINOMA; TYPE IV SECRETION SYSTEM; UPREGULATION; VIRUS REPLICATION; XENOPHAGY;

AUTOPHAGY; EBV; GASTRIC CANCER; H. PYLORI;

ANIMALS; AUTOPHAGY; CELL TRANSFORMATION, NEOPLASTIC; CELL TRANSFORMATION, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HERPESVIRUS 4, HUMAN; HUMANS; STOMACH NEOPLASMS; VIRULENCE FACTORS; VIRUS REPLICATION;

EID: 84900522505     PISSN: 00223417     EISSN: 10969896     Source Type: Journal    
DOI: 10.1002/path.4351     Document Type: Review

References (131)

1. Bu Z, Ji J,. Therapeutic implications of mTOR inhibitors in the treatment of gastric cancer. Curr Cancer Drug Targets 2013; 13: 121-125.
2. Jemal A, Bray F, Center MM, et al., Global cancer statistics. CA Cancer J Clin 2011; 61: 69-90.
3. Arnold M, Karim-Kos HE, Coebergh JW, et al., Recent trends in incidence of five common cancers in 26 European countries since 1988: analysis of the European Cancer Registry database. Eur J Cancer 2013; doi: 10.1016/j.ejca.2013. 09.002.
4. Moran AP, Gupta A, Joshi L,. Sweet-talk: role of host glycosylation in bacterial pathogenesis of the gastrointestinal tract. Gut 2013; 60: 1412-1425.
5. Dicksved J, Lindberg M, Rosenquist M, et al., Molecular characterization of the stomach microbiota in patients with gastric cancer and in controls. J Med Microbiol 2009; 58: 509-516.
6. Israel DA, Peek RM,. Surreptitious manipulation of the human host by Helicobacter pylori. Gut Microbes 2010; 1: 119-127.
7. Helicobacter and Cancer Collaborative Group. Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts. Gut 2001; 49: 347-353.
8. Shibata D, Weiss LM,. Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 1992; 140: 769-774.
9. Hsieh LL, Lin PJ, Chen TC, et al., Frequency of Epstein-Barr virus-associated gastric adenocarcinoma in Taiwan. Cancer Lett 1998; 129: 125-29.
10. Morewaya J, Koriyama C, Akiba S, et al., Epstein-Barr virus-associated gastric carcinoma in Papua New Guinea. Oncol Rep 2004; 12: 1093-1098.
11. Kim KW, Paul P, Qiao J, et al., Enhanced autophagy blocks angiogenesis via degradation of gastrin-releasing peptide in neuroblastoma cells. Autophagy 2013; 9: 1579-1590.
12. Mizushima N, Levine B, Cuervo AM, et al., Autophagy fights disease through cellular self-digestion. Nature 2008; 451: 1069-1075.
13. Mathew R, Kongara S, Beaudoin B, et al., Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev 2007; 21: 1367-1381.
14. Saitoh T, Fujita N, Jang MH, et al., Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1β production. Nature 2008; 456: 264-268.
15. Ling J, Kang Y, Zhao R, et al., KrasG12D-induced IKK2/β/NF-κB activation by IL-1α and p62 feedforward loops is required for development of pancreatic ductal adenocarcinoma. Cancer Cell 2012; 21: 105-120.
16. Inami Y, Waguri S, Sakamoto A, et al., Persistent activation of Nrf2 through p62 in hepatocellular carcinoma cells. J Cell Biol 2011; 193: 275-284.
17. Yu H, Su J, Xu Y, et al., p62/SQSTM1 involved in cisplatin resistance in human ovarian cancer cells by clearing ubiquitinated proteins. Eur J Cancer 2011; 47: 1585-1594.
18. Galavotti S, Bartesaghi S, Faccenda D, et al., The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells. Oncogene 2013; 32: 699-712.
19. Parkhitko A, Myachina F, Morrison TA, et al., Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent. Proc Natl Acad Sci USA 2011; 108: 12455-12460.
20. He C, Klionsky DJ,. Regulation mechanisms and signaling pathways of autophagy. Annu Rev Genet 2009; 43: 67-93.
21. Degenhardt K, Mathew R, Beaudoin B, et al., Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 2006; 10: 51-64.
22. Oehme I, Linke JP, Bock BC, et al., Histone deacetylase 10 promotes autophagy-mediated cell survival. Proc Natl Acad Sci USA 2013; 110: E2592-2601.
23. Castillo EF, Dekonenko A, Arko-Mensah J, et al., Autophagy protects against active tuberculosis by suppressing bacterial burden and inflammation. Proc Natl Acad Sci USA 2012; 109: E3168-3176.
24. Hu Z, Zhang J, Zhang Q,. Expression pattern and functions of autophagy-related gene atg5 in zebrafish organogenesis. Autophagy 2011; 7: 1514-1527.
25. Nishida Y, Arakawa S, Fujitani K, et al., Discovery of Atg5/Atg7-independent alternative macroautophagy. Nature 2009; 461: 654-658.
26. Kang R, Zeh HJ, Lotze MT, et al., The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ 2011; 18: 571-580.
27. Russell RC, Tian Y, Yuan H, et al., ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol 2013; 15: 741-750.
28. Huang J, Canadien V, Lam GY, et al., Activation of antibacterial autophagy by NADPH oxidases. Proc Natl Acad Sci USA 2009; 106: 6226-6231.
29. Wu WK, Coffelt SB, Cho CH, et al., The autophagic paradox in cancer therapy. Oncogene 2012; 31: 939-953.
30. Kang MR, Kim MS, Oh JE, et al., Frameshift mutations of autophagy-related genes ATG2B, ATG5, ATG9B and ATG12 in gastric and colorectal cancers with microsatellite instability. J Pathol 2009; 217: 702-706.
31. An CH, Kim MS, Yoo NJ, et al., Mutational and expressional analyses of ATG5, an autophagy-related gene, in gastrointestinal cancers. Pathol Res Pract 2011; 207: 433-437.
32. Geng QR, Xu DZ, He LJ, et al., Beclin-1 expression is a significant predictor of survival in patients with lymph node-positive gastric cancer. PLoS One 2012; 7: e45968.
33. Yu M, Gou WF, Zhao S, et al., Beclin 1 expression is an independent prognostic factor for gastric carcinomas. Tumour Biol 2013; 34: 1071-1083.
34. Ahn CH, Jeong EG, Lee JW, et al., Expression of beclin-1, an autophagy-related protein, in gastric and colorectal cancers. Acta Pathol Microbiol Immunol Scand 2007; 115: 1344-1349.
35. Zhou WH, Tang F, Xu J, et al., Low expression of Beclin 1, associated with high Bcl-xL, predicts a malignant phenotype and poor prognosis of gastric cancer. Autophagy 2012; 8: 389-400.
36. Yoshioka A, Miyata H, Doki Y, et al., LC3, an autophagosome marker, is highly expressed in gastrointestinal cancers. Int J Oncol 2008; 33: 461-468.
37. Levine B., Eating oneself and uninvited guests: autophagy-related pathways in cellular defense. Cell 2005; 120: 159-162.
38. Kobayashi H, Sunako M, Hayashi M, et al., DNA synthesis and fragmentation in bacteroids during Astragalus sinicus root nodule development. Biosci Biotechnol Biochem 2001; 65: 510-515.
39. Turco J, Winkler HH,. Role of the nitric oxide synthase pathway in inhibition of growth of interferon-sensitive and interferon-resistant Rickettsia prowazekii strains in L929 cells treated with tumor necrosis factor-α and γ-interferon. Infect Immun 1993; 61: 4317-4325.
40. Turco J, Liu H, Gottlieb SF, et al., Nitric oxide-mediated inhibition of the ability of Rickettsia prowazekii to infect mouse fibroblasts and mouse macrophage-like cells. Infect Immun 1998; 66: 558-566.
41. Walker DH, Popov VL, Crocquet-Valdes PA, et al., Cytokine-induced, nitric oxide-dependent, intracellular antirickettsial activity of mouse endothelial cells. Lab Invest 1997; 76: 129-138.
42. Rich KA, Burkett C, Webster P,. Cytoplasmic bacteria can be targets for autophagy. Cell Microbiol 2003; 5: 455-468.
43. Wymann MP, Bulgarelli-Leva G, Zvelebil MJ, et al., Wortmannin inactivates phosphoinositide 3-kinase by covalent modification of Lys-802, a residue involved in the phosphate transfer reaction. Mol Cell Biol 1996; 16: 1722-1733.
44. Yuan K, Huang C, Fox J, et al., Autophagy plays an essential role in the clearance of Pseudomonas aeruginosa by alveolar macrophages. J Cell Sci 2012; 125: 507-515.
45. Fujita N, Morita E, Itoh T, et al., Recruitment of the autophagic machinery to endosomes during infection is mediated by ubiquitin. J Cell Biol 2013; 203: 115-28.
46. Marchiando AM, Ramanan D, Ding Y, et al., A deficiency in the autophagy gene Atg16L1 enhances resistance to enteric bacterial infection. Cell Host Microbe 2013; 14: 216-224.
47. Watson RO, Manzanillo PS, Cox JS,. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway. Cell 2013; 150: 803-815.
48. Charrel-Dennis M, Latz E, Halmen KA, et al., TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. Cell Host Microbe 2008; 4: 543-554.
49. Herskovits AA, Auerbuch V, Portnoy DA,. Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. PLoS Pathog 2007; 3: e51.
50. Progulske-Fox A, Kozarov E, Dorn B, et al., Porphyromonas gingivalis virulence factors and invasion of cells of the cardiovascular system. J Periodontal Res 1999; 34: 393-399.
51. Dorn BR, Dunn WA Jr, Progulske-Fox A,. Porphyromonas gingivalis traffics to autophagosomes in human coronary artery endothelial cells. Infect Immun 2001; 69: 5698-5708.
52. Ben-Tekaya H, Gorvel JP, Dehio C,. Bartonella and Brucella-weapons and strategies for stealth attack. Cold Spring Harb Perspect Med 2013; 3: a010231.
53. Joshi AD, Swanson MS,. Secrets of a successful pathogen: Legionella resistance to progression along the autophagic pathway. Front Microbiol 2011; 2: 138.
54. Swanson MS, Fernandez-Moreira E,. A microbial strategy to multiply in macrophages: the pregnant pause. Traffic (Copenhagen, Denmark) 2002; 3: 170-77.
55. Monroe KM, McWhirter SM, Vance RE,. Identification of host cytosolic sensors and bacterial factors regulating the type I interferon response to Legionella pneumophila. PLoS Pathog 2009; 5: e1000665.
56. Jehl SP, Nogueira CV, Zhang X, et al., IFNγ inhibits the cytosolic replication of Shigella flexneri via the cytoplasmic RNA sensor RIG-I. PLoS Pathog 2012; 8: e1002809.
57. Vogel JP, Andrews HL, Wong SK, et al., Conjugative transfer by the virulence system of Legionella pneumophila. Science 1998; 279: 873-876.
58. Lee VW, Chan AK, Lee KK, et al., Non-invasive serological detection of Helicobacter pylori antigens in adult Hong Kong Chinese non-ulcer dyspepsia patients. Curr Microbiol 2007; 54: 249-253.
59. Johnson EM, Gaddy JA, Cover TL,. Alterations in Helicobacter pylori triggered by contact with gastric epithelial cells. Front Cell Infect Microbiol 2012; 2: 17.
60. Ilver D, Barone S, Mercati D, et al., Helicobacter pylori toxin VacA is transferred to host cells via a novel contact-dependent mechanism. Cell Microbiol 2004; 6: 167-174.
61. Montecucco C, de Bernard M,. Molecular and cellular mechanisms of action of the vacuolating cytotoxin (VacA) and neutrophil-activating protein (HP-NAP) virulence factors of Helicobacter pylori. Microbes Infect 2003; 5: 715-721.
62. Cover TL, Blanke SR,. Helicobacter pylori VacA, a paradigm for toxin multifunctionality. Nat Rev Microbiol 2005; 3: 320-332.
63. Cover TL, Dooley CP, Blaser MJ,. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity. Infect Immun 1990; 58: 603-610.
64. Cover TL, Halter SA, Blaser MJ,. Characterization of HeLa cell vacuoles induced by Helicobacter pylori broth culture supernatant. Hum Pathol 1992; 23: 1004-1010.
65. Raju D, Jones NL,. Methods to monitor autophagy in H. pylori vacuolating cytotoxin A (VacA)-treated cells. Autophagy 2010; 6: 138-143.
66. Raju D, Rizzuti D, Jones NL,. Cell culture assays to evaluate bacterial toxicity and virulence. Methods Mol Biol 2012; 921: 77-88.
67. Terebiznik MR, Raju D, Vazquez CL, et al., Effect of Helicobacter pylori's vacuolating cytotoxin on the autophagy pathway in gastric epithelial cells. Autophagy 2009; 5: 370-379.
68. Wang YH, Wu JJ, Lei HY,. The autophagic induction in Helicobacter pylori-infected macrophage. Exp Biol Med 2009; 234: 171-180.
69. Tombola F, Oregna F, Brutsche S, et al., Inhibition of the vacuolating and anion channel activities of the VacA toxin of Helicobacter pylori. FEBS Lett 1999; 460: 221-225.
70. Yahiro K, Satoh M, Nakano M, et al., Low-density lipoprotein receptor-related protein-1 (LRP1) mediates autophagy and apoptosis caused by Helicobacter pylori VacA. J Biol Chem 2012; 287: 31104-31115.
71. Tsugawa H, Suzuki H, Saya H, et al., Reactive oxygen species-induced autophagic degradation of Helicobacter pylori CagA is specifically suppressed in cancer stem-like cells. Cell Host Microbe 2012; 12: 764-777.
72. Raju D, Hussey S, Jones NL,. Crohn disease ATG16L1 polymorphism increases susceptibility to infection with Helicobacter pylori in humans. Autophagy 2012; 8: 1387-1388.
73. Bjorkoy G, Lamark T, Brech A, et al., p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on huntingtin-induced cell death. J Cell Biol 2005; 171: 603-614.
74. Ponpuak M, Davis AS, Roberts EA, et al., Delivery of cytosolic components by autophagic adaptor protein p62 endows autophagosomes with unique antimicrobial properties. Immunity 2010; 32: 329-341.
75. Raju D, Hussey S, Ang M, et al., Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans. Gastroenterology 2012; 142: 1160-1171.
76. Raj L, Ide T, Gurkar AU, et al., Selective killing of cancer cells by a small molecule targeting the stress response to ROS. Nature 2011; 475: 231-234.
77. Ren F, Shu G, Liu G, et al., Knockdown of p62/sequestosome 1 attenuates autophagy and inhibits colorectal cancer cell growth. Mol Cell Biochem 2014; 385: 95-102.
78. Tegtmeyer N, Wessler S, Backert S,. Role of the cag-pathogenicity island encoded type IV secretion system in Helicobacter pylori pathogenesis. FEBS J 2011; 278: 1190-1202.
79. Yamahashi Y, Hatakeyama M,. PAR1b takes the stage in the morphogenetic and motogenetic activity of Helicobacter pylori CagA oncoprotein. Cell Adh Migr 2013; 7: 11-18.
80. Belogolova E, Bauer B, Pompaiah M, et al., Helicobacter pylori outer membrane protein HopQ identified as a novel T4SS-associated virulence factor. Cell Microbiol 2013; 15: 1896-1912.
81. Krueger S, Hundertmark T, Kuester D, et al., Helicobacter pylori alters the distribution of ZO-1 and p120ctn in primary human gastric epithelial cells. Pathol Res Pract 2007; 203: 433-444.
82. Hayashi Y, Tsujii M, Wang J, et al., CagA mediates epigenetic regulation to attenuate let-7 expression in Helicobacter pylori-related carcinogenesis. Gut 2013; 62: 1536-1546.
83. + strains and dissociation of gastric epithelial cell proliferation from apoptosis. J Natl Cancer Inst 1997; 89: 863-868.
84. Murata-Kamiya N, Kikuchi K, Hayashi T, et al., Helicobacter pylori exploits host membrane phosphatidylserine for delivery, localization, and pathophysiological action of the CagA oncoprotein. Cell Host Microbe 2010; 7: 399-411.
85. Parsonnet J, Friedman GD, Orentreich N, et al., Risk for gastric cancer in people with CagA-positive or CagA-negative Helicobacter pylori infection. Gut 1997; 40: 297-301.
86. Ohnishi N, Yuasa H, Tanaka S, et al., Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse. Proc Natl Acad Sci USA 2008; 105: 1003-1008.
87. Yamazaki S, Yamakawa A, Ito Y, et al., The CagA protein of Helicobacter pylori is translocated into epithelial cells and binds to SHP-2 in human gastric mucosa. J Infect Dis 2003; 187: 334-337.
88. Riddler SA, Breinig MC, McKnight JL,. Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients. Blood 1994; 84: 972-984.
89. Green MR, Rodig S, Juszczynski P, et al., Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy. Clin Cancer Res 2012; 18: 1611-1118.
90. Dumont J, Liabeuf A, Henle W, et al., Anti-EBV antibody titers in non-Hodgkin lymphomas. Int J Cancer 1976; 18: 14-23.
91. Hanel P, Hummel M, Anagnostopoulos I, et al., Analysis of single EBER-positive and negative tumour cells in EBV-harbouring B-cell non-Hodgkin lymphomas. J Pathol 2001; 195: 355-360.
92. Iamaroon A, Pongsiriwet S, Mahanupab P, et al., Oral non-Hodgkin lymphomas: studies of EBV and p53 expression. Oral Dis 2003; 9: 14-18.
93. Klumb CE, Hassan R, Zalcberg IR, et al., p53 protein expression does not correlate with EBV status in childhood B non-Hodgkin lymphomas. Pediatr Blood Cancer 2004; 43: 115-119.
94. Pietersma F, Piriou E, van Baarle D,. Immune surveillance of EBV-infected B cells and the development of non-Hodgkin lymphomas in immunocompromised patients. Leuk Lymphoma 2008; 49: 1028-1041.
95. Camargo MC, Murphy G, Koriyama C, et al., Determinants of Epstein-Barr virus-positive gastric cancer: an international pooled analysis. Br J Cancer 2011; 105: 38-43.
96. Chen JN, He D, Tang F, et al., Epstein-Barr virus-associated gastric carcinoma: a newly defined entity. J Clin Gastroenterol 2012; 46: 262-271.
97. Camargo MC, Koriyama C, Matsuo K, et al., Case-case comparison of smoking and alcohol risk associations with Epstein-Barr virus-positive gastric cancer. Int J Cancer 2014; 134: 948-953.
98. Cardenas-Mondragon MG, Carreon-Talavera R, Camorlinga-Ponce M, et al., Epstein Barr virus and Helicobacter pylori co-infection are positively associated with severe gastritis in pediatric patients. PLoS One 2012; 8: e62850.
99. Zhao J, Liang Q, Cheung KF, et al., Somatostatin receptor 1, a novel EBV-associated CpG-hypermethylated gene, contributes to the pathogenesis of EBV-associated gastric cancer. Br J Cancer 2013; 108: 2557-2564.
100. Maxwell KL, Frappier L,. Viral proteomics. Microbiol Mol Biol Rev 2007; 71: 398-411.
101. Ding Y, Li XR, Yang KY, et al., Proteomics analysis of gastric epithelial AGS cells infected with Epstein-Barr virus. Asian Pac J Cancer Prev 2013; 14: 367-372.
102. Strong MJ, Xu G, Coco J, et al., Differences in gastric carcinoma microenvironment stratify according to EBV infection intensity: implications for possible immune adjuvant therapy. PLoS Pathog 2013; 9: e1003341.
103. Chang MS, Kim DH, Roh JK, et al., Epstein-Barr virus-encoded BARF1 promotes proliferation of gastric carcinoma cells through regulation of NF-κB. J Virology 2013; 87: 10515-10523.
104. Mizushima N, Komatsu M,. Autophagy: renovation of cells and tissues. Cell 2011; 147: 728-741.
105. Choi AM, Ryter SW, Levine B,. Autophagy in human health and disease. N Engl J Med 2013; 368: 1845-1846.
106. Orvedahl A, MacPherson S, Sumpter R, Jr,., et al. Autophagy protects against Sindbis virus infection of the central nervous system. Cell Host Microbe 2010; 7: 115-127.
107. Cavignac Y, Esclatine A,. Herpesviruses and autophagy: catch me if you can! Viruses 2010; 2: 314-33.
108. Suhy DA, Giddings TH Jr, Kirkegaard K,. Remodeling the endoplasmic reticulum by poliovirus infection and by individual viral proteins: an autophagy-like origin for virus-induced vesicles. J Virol 2000; 74: 8953-8965.
109. Rodriguez-Rocha H, Gomez-Gutierrez JG, Garcia-Garcia A, et al., Adenoviruses induce autophagy to promote virus replication and oncolysis. Virology 2011; 416: 9-15.
110. Gregoire IP, Richetta C, Meyniel-Schicklin L, et al., IRGM is a common target of RNA viruses that subvert the autophagy network. PLoS Pathog 2011; 7: e1002422.
111. Kerr BM, Lear AL, Rowe M, et al., Three transcriptionally distinct forms of Epstein-Barr virus latency in somatic cell hybrids: cell phenotype dependence of virus promoter usage. Virology 1992; 187: 189-201.
112. Humme S, Reisbach G, Feederle R, et al., The EBV nuclear antigen 1 (EBNA1) enhances B cell immortalization several thousandfold. Proc Natl Acad Sci USA 2003; 100: 10989-10994.
113. English L, Chemali M, Duron J, et al., Autophagy enhances the presentation of endogenous viral antigens on MHC class I molecules during HSV-1 infection. Nat Immunol 2009; 10: 480-487.
114. Dengjel J, Schoor O, Fischer R, et al., Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc Natl Acad Sci USA 2005; 102: 7922-7927.
115. Paludan C, Schmid D, Landthaler M, et al., Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 2005; 307: 593-596.
116. Nakamoto M, Moy RH, Xu J, et al., Virus recognition by Toll-7 activates antiviral autophagy in Drosophila. Immunity 2012; 36: 658-667.
117. Shelly S, Lukinova N, Bambina S, et al., Autophagy is an essential component of Drosophila immunity against vesicular stomatitis virus. Immunity 2009; 30: 588-598.
118. Severa M, Giacomini E, Gafa V, et al., EBV stimulates TLR- and autophagy-dependent pathways and impairs maturation in plasmacytoid dendritic cells: implications for viral immune escape. Eur J Immunol 2013; 43: 147-158.
119. Fathallah I, Parroche P, Gruffat H, et al., EBV latent membrane protein 1 is a negative regulator of TLR9. J Immunol 2010; 185: 6439-6447.
120. Dreux M, Gastaminza P, Wieland SF, et al., The autophagy machinery is required to initiate hepatitis C virus replication. Proc Natl Acad Sci USA 2009; 106: 14046-14051.
121. Lee DY, Sugden B,. The latent membrane protein 1 oncogene modifies B-cell physiology by regulating autophagy. Oncogene 2008; 27: 2833-2842.
122. Kouroku Y, Fujita E, Tanida I, et al., ER stress (PERK/eIF2α phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ 2007; 14: 230-239.
123. Py BF, Boyce M, Yuan J,. A critical role of eEF-2 K in mediating autophagy in response to multiple cellular stresses. Autophagy 2009; 5: 393-396.
124. Zhu K, Dunner K, Jr., McConkey DJ,. Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene 2010; 29: 451-462.
125. Zhang L, Yu J, Pan H, et al., Small molecule regulators of autophagy identified by an image-based high-throughput screen. Proc Natl Acad Sci USA 2007; 104: 19023-19028.
126. Sundaramurthy V, Barsacchi R, Samusik N, et al., Integration of chemical and RNAi multiparametric profiles identifies triggers of intracellular mycobacterial killing. Cell Host Microbe 2013; 13: 129-142.
127. Bonsch C, Kempf C, Mueller I, et al., Chloroquine and its derivatives exacerbate B19V-associated anemia by promoting viral replication. PLoS Negl Trop Dis 2010; 4: e669.
128. Byrd TF, Horwitz MA,. Chloroquine inhibits the intracellular multiplication of Legionella pneumophila by limiting the availability of iron. A potential new mechanism for the therapeutic effect of chloroquine against intracellular pathogens. J Clin Invest 1991; 88: 351-357.
129. Henriet SS, Jans J, Simonetti E, et al., Chloroquine modulates the fungal immune response in phagocytic cells from patients with chronic granulomatous disease. J Infect Dis 2013; 207: 1932-1939.
130. Rolain JM, Colson P, Raoult D,. Recycling of chloroquine and its hydroxyl analogue to face bacterial, fungal and viral infections in the 21st century. Int J Antimicrob Agents 2007; 30: 297-308.
131. Ham H, Sreelatha A, Orth K,. Manipulation of host membranes by bacterial effectors. Nat Rev Microbiol 2011; 9: 635-646.